top of page

Andrew E. Sloan Lab

Innovative Neuro-Oncology Research

Lab Picture 041322.jpg
Home: Welcome

Andrew E. Sloan

Chairman, Department of Neurosurgery
Piedmont Health, Atlanta Georgia

Dr. Sloan focuses on clinical and translational approaches to the treatment of malignant brain tumors and has been funded by NIH, NCI, the Ohio Third Frontier organization, the American Society of Clinical Oncology (ASCO), The American Brain Tumor Association (ABTA), the Adult Brain Tumor Consortium (ABTC), Howard Hughes Medical Institute (HHMI), and other national organizations, as well as several pharmaceutical companies.  He has more than 210 peer-reviewed publications, 6 US patents and INDs, and more than 600 invited presentations, and sits on the editorial boards of several neurosurgical and general medical journals.

sloan1jpg_edited_edited_edited.jpg
Home: Our Team

Key Publications

We are proud to showcase the results of research undertaken by members of our interdisciplinary Scientific Research Laboratory. Our work and findings have been published in a number of prestigious publications in our field.

A Liquid Biopsy to Assess Brain Tumor Recurrence: Presence of Circulating Mo-MDSC and CD14+ VNN2+ Myeloid Cells as Biomarkers that Distinguish Brain Metastasis from Radiation Necrosis Following Stereotactic Radiosurgery

21 August 2020

Neurosurgery  88(1): E67-E72

Proteins Inform Survival-Based Differences in Patients with Glioblastoma

17 March 2020

Neuro-Oncology Advances 2(1) 1-11

Plant Virus-Like Particle In Situ Vaccine for Intracranial Glioma Immunotherapy

10 April 2019

Cancers (Basel)  11(4): 515

The Ratio of HLA-DR and VNN2+ Expression on CD14+ Myeloid Derived Suppressor Cells Can Distinguish Glioblastoma from Radiation Necrosis Patients

27 May 2017

Neurooncol 134(1): 189-196

Targeting Glioma Stem Cells Through Combined BMI1 and EZH2 Inhibition

9 October 2017

Nature Medicine  23: 1352-1361

Home: Publications
bottom of page